Comparative Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors vs Sulfonylureas in Patients With Type 2 Diabetes-Reply

Affiliations

Comment

Ziyad Al-Aly et al. JAMA Intern Med. 2022.

. 2022 Jan 1;182(1):93-94.

doi: 10.1001/jamainternmed.2021.6334.

¹ Clinical Epidemiology Center, Research and Development Service, VA St Louis Health Care System, St Louis, Missouri.

No abstract available

Comment on

Comparative Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors vs Sulfonylureas in Patients With Type 2 Diabetes.
Xie Y, Bowe B, Gibson AK, McGill JB, Maddukuri G, Al-Aly Z. Xie Y, et al. JAMA Intern Med. 2021 Aug 1;181(8):1043-1053. doi: 10.1001/jamainternmed.2021.2488. JAMA Intern Med. 2021. PMID: 34180939 Free PMC article.
Comparative Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors vs Sulfonylureas in Patients With Type 2 Diabetes.
Goldberg D. Goldberg D. JAMA Intern Med. 2022 Jan 1;182(1):93. doi: 10.1001/jamainternmed.2021.6321. JAMA Intern Med. 2022. PMID: 34724024 No abstract available.